Susquehanna International Group
BIO icon

Susquehanna International Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Susquehanna International Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$781K Buy
2,800
+700
+33% +$202K ﹤0.01% 8530
2025
Q4 		$636K Sell
2,100
-200
-9% -$62.4K ﹤0.01% 8248
2025
Q3 		$645K Sell
2,300
-12,200
-84% -$3.32M ﹤0.01% 8389
2025
Q2 		$3.5M Buy
14,500
+6,300
+77% +$1.49M ﹤0.01% 4667
2025
Q1 		$2M Buy
8,200
+400
+5% +$120K ﹤0.01% 5544
2024
Q4 		$2.56M Buy
7,800
+300
+4% +$102K ﹤0.01% 4770
2024
Q3 		$2.51M Sell
7,500
-13,700
-65% -$4.35M ﹤0.01% 4849
2024
Q2 		$5.79M Sell
21,200
-37,500
-64% -$10.9M ﹤0.01% 3212
2024
Q1 		$20.3M Buy
58,700
+20,100
+52% +$6.61M ﹤0.01% 1769
2023
Q4 		$12.5M Buy
38,600
+10,500
+37% +$3.29M ﹤0.01% 2354
2023
Q3 		$10.1M Sell
28,100
-16,200
-37% -$6.25M ﹤0.01% 2566
2023
Q2 		$16.8M Sell
44,300
-7,900
-15% -$3.21M ﹤0.01% 1909
2023
Q1 		$25M Buy
52,200
+9,000
+21% +$4.21M 0.01% 1480
2022
Q4 		$18.2M Buy
43,200
+6,000
+16% +$2.42M ﹤0.01% 1623
2022
Q3 		$15.5M Buy
37,200
+5,200
+16% +$2.59M ﹤0.01% 1661
2022
Q2 		$15.8M Sell
32,000
-11,100
-26% -$5.78M ﹤0.01% 1664
2022
Q1 		$24.3M Buy
43,100
+2,500
+6% +$1.51M ﹤0.01% 1529
2021
Q4 		$30.7M Buy
40,600
+11,200
+38% +$8.38M ﹤0.01% 1449
2021
Q3 		$21.9M Sell
29,400
-31,300
-52% -$23.4M ﹤0.01% 1880
2021
Q2 		$39.1M Buy
60,700
+44,100
+266% +$26.8M 0.01% 1386
2021
Q1 		$9.48M Sell
16,600
-2,700
-14% -$1.6M ﹤0.01% 2857
2020
Q4 		$11.3M Sell
19,300
-1,100
-5% -$626K ﹤0.01% 2363
2020
Q3 		$10.5M Buy
20,400
+600
+3% +$304K ﹤0.01% 2117
2020
Q2 		$8.94M Sell
19,800
-11,000
-36% -$4.85M ﹤0.01% 2267
2020
Q1 		$10.8M Buy
30,800
+16,900
+122% +$6.21M ﹤0.01% 1656
2019
Q4 		$5.14M Sell
13,900
-11,600
-45% -$4.09M ﹤0.01% 2930
2019
Q3 		$8.48M Buy
25,500
+13,100
+106% +$4.27M ﹤0.01% 2149
2019
Q2 		$3.88M Sell
12,400
-8,500
-41% -$2.55M ﹤0.01% 3074
2019
Q1 		$6.39M Buy
20,900
+18,500
+771% +$4.99M ﹤0.01% 2183
2018
Q4 		$557K Sell
2,400
-2,200
-48% -$590K ﹤0.01% 5809
2018
Q3 		$1.44M Sell
4,600
-3,300
-42% -$1.02M ﹤0.01% 4556
2018
Q2 		$2.28M Buy
7,900
+3,700
+88% +$1.02M ﹤0.01% 3792
2018
Q1 		$1.05M Sell
4,200
-13,700
-77% -$3.49M ﹤0.01% 5131
2017
Q4 		$4.27M Buy
17,900
+14,200
+384% +$3.44M ﹤0.01% 2727
2017
Q3 		$822K Sell
3,700
-900
-20% -$203K ﹤0.01% 5626
2017
Q2 		$1.04M Sell
4,600
-11,900
-72% -$2.59M ﹤0.01% 5171
2017
Q1 		$3.29M Buy
16,500
+12,500
+313% +$2.41M ﹤0.01% 2899
2016
Q4 		$729K Buy
4,000
+800
+25% +$136K ﹤0.01% 6185
2016
Q3 		$524K Buy
+3,200
New +$486K ﹤0.01% 5976
2016
Q2 		– Sell
-5,100
Closed -$697K – 8532
2016
Q1 		$697K Buy
5,100
+2,600
+104% +$341K ﹤0.01% 5805
2015
Q4 		$347K Sell
2,500
-200
-7% -$27.7K ﹤0.01% 7431
2015
Q3 		$363K Buy
+2,700
New +$389K ﹤0.01% 7704
2014
Q3 		– Sell
-1,900
Closed -$227K – 9423
2014
Q2 		$227K Sell
1,900
-1,100
-37% -$134K ﹤0.01% 8855
2014
Q1 		$384K Buy
3,000
+400
+15% +$51.3K ﹤0.01% 7189
2013
Q4 		$321K Sell
2,600
-400
-13% -$48.7K ﹤0.01% 7476
2013
Q3 		$353K Buy
+3,000
New +$354K ﹤0.01% 6968

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's BIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 2,938 shares worth $819K. The stake represents ﹤0.01% of the portfolio and ranks #8416 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BIO as recently as Q3 2025.

Susquehanna International Group first reported a position in BIO in Q2 2013 and has held it in 38 quarters since. The position peaked at $16.9M in Q2 2019. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Susquehanna International Group held 2,938 shares of Bio-Rad Laboratories Class A worth $819K as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new Susquehanna International Group position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8416 holding.
  • Susquehanna International Group first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 38 quarters since.
  • Susquehanna International Group's Bio-Rad Laboratories Class A position peaked at $16.9M in Q2 2019.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.